O'Donnell Financial Services’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-43,410
Closed -$29.2K 31
2023
Q2
$29.2K Hold
43,410
0.02% 24
2023
Q1
$60.3K Hold
43,410
0.11% 20
2022
Q4
$54.7K Sell
43,410
-499
-1% -$1.14K 0.5% 16
2022
Q3
$189K Buy
43,909
+85
+0.2% +$421 0.66% 23
2022
Q2
$229K Buy
43,824
+1,105
+3% +$10.4K 0.19% 32
2022
Q1
$512K Buy
42,719
+88
+0.2% +$1.2K 0.23% 22
2021
Q4
$629K Buy
42,631
+595
+1% +$13.3K 0.29% 22
2021
Q3
$1.09M Buy
+42,036
New +$991K 0.53% 23

Other funds holding NMTR

O'Donnell Financial Services's NMTR Position: Q3 2023 in Review

O'Donnell Financial Services sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 43,410 shares — an estimated $29.2K sold.

O'Donnell Financial Services first reported a position in NMTR in Q3 2021 and held it in 8 quarters. The position peaked at $1.09M in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • O'Donnell Financial Services reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • O'Donnell Financial Services sold 43,410 9 Meters Biopharma shares in Q3 2023, an estimated $29.2K.
  • O'Donnell Financial Services first reported a position in 9 Meters Biopharma in Q3 2021 and held it in 8 quarters.
  • O'Donnell Financial Services's 9 Meters Biopharma position peaked at $1.09M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on O'Donnell Financial Services's 13F filing for Q3 2023, filed 19 Oct 2023.